CDW Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CDW Corporation on November 13, 2013, with the report date reflecting the earliest event reported on that same day. The filing documents the entry into a material definitive agreement regarding a secondary public offering of common stock.
Key Financial Metrics
The filing details a transaction involving the sale of 15,000,000 shares of CDW Corporation common stock by Selling Stockholders at a public offering price of $20.50 per share. An option was granted to underwriters to purchase up to an additional 2,250,000 shares within 30 days. The closing of the offering occurred on November 19, 2013.
Proceeds: The filing explicitly states that CDW Corporation did not receive any proceeds from the sale of these shares, as the transaction was conducted entirely by Selling Stockholders.
Other Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics, as this report focuses solely on the equity transaction.
Material Changes
The primary material change is the dilution of existing shareholders due to the issuance of new shares by Selling Stockholders. The total number of shares outstanding increased by 15,000,000 (plus potential additional shares if the underwriters' option is exercised). There is no change to the company's capital structure regarding debt or cash reserves from this specific transaction.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or outlook for future periods. It does not disclose specific risks or contingencies beyond the standard terms of the underwriting agreement. The transaction was executed pursuant to a Registration Statement on Form S-3ASR filed on November 8, 2013.
Key Facts for Investor Verification
- Verify the identity of the Selling Stockholders to understand the nature of the share reduction (e.g., insider selling vs. institutional exit).
- Confirm whether the underwriters exercised the option to purchase the additional 2,250,000 shares.
- Review the impact of the 15,000,000 new shares on earnings per share (EPS) dilution in subsequent quarterly reports.
- Check the total proceeds generated by the Selling Stockholders (15,000,000 shares x $20.50 = $307.5 million, excluding underwriting discounts).